Metabolic effects of androgenotherapy: impact on glucolipotoxicity in patients with type 2 diabetes mellitus and visceral obesity
AbstractTestosterone replacement therapy in patients with type 2 diabetes mellitus, visceral obesity and androgenotherapy improves metabolic characteristics of carbohydrate and lipid metabolism, and elimination of state glucolipotoxicity.
Keywords:type 2 diabetes mellitus, glucolipotoxicity, testosterone deficiency, androgenotherapy